Vimarsana
Biggest News Aggregation in the World

Page 3 - Authorisation Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Authorisation Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Authorisation Application Today - Breaking & Trending Today

United Kingdom: UKs MHRA announces extension of the European Commission Decision Reliance Procedure (ECDRP) - Vimarsana News

United Kingdom: UKs MHRA announces extension of the European Commission Decision Reliance Procedure (ECDRP)

Before 31 December 2023, in situations where a Committee for Medicinal Products for Human Use (CHMP) positive opinion has been received, applicants…

SIFI and Avanzanite announce AKANTIOR agreement - Vimarsana News

SIFI and Avanzanite announce AKANTIOR agreement

Partnership offers treatment access to hundreds of patients across several European countries - News - PharmaTimes

Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate - Vimarsana News

Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate

01.12.2022 - Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination scheduleHigher antibody levels were observed in the three-dose vaccination schedule versus the two-dose ...

GenSight Biologics S.A.: GenSight Biologics Granted Six-Month Extension in LUMEVOQ European Regulatory Review - Vimarsana News

GenSight Biologics S.A.: GenSight Biologics Granted Six-Month Extension in LUMEVOQ European Regulatory Review

New submission date for Day 120 responses: October 2022 Restart of validation batches in Q3 2022 Committee for Medicinal Products for Human Use (CHMP) opinion expected by Q3 2023 Regulatory

Orphazyme provides regulatory update following Type A - Vimarsana News

Orphazyme provides regulatory update following Type A

Orphazyme A/SCompany announcement        No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential...